QSAR Study of Benzothiazole Derivatives as p56lck Inhibitors

E-ISSN： 1875-628x|3|8|550-560

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.8, 2006-10, pp. : 550-560

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A QSAR Study on a Series of Pyrrole Derivatives Acting as Lymphocyte- Specific Kinase (Lck) Inhibitors

Medicinal Chemistry, Vol. 8, Iss. 4, 2012-07 ,pp. : 649-655

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of p56lck: assessing their potential as tools for manipulating T-lymphocyte activation

By Dowden J. Ward S.G.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 2, 2001-02 ,pp. : 295-306

Informa Healthcare

Access to resources Recommend Favorite

4-Thiophenoxy-N-(3,4,5-Trialkoxyphenyl)Pyrimidine-2-Amines as Potent and Selective Inhibitors of the T-Cell Tyrosine Kinase p56lck

Current Medicinal Chemistry, Vol. 11, Iss. 6, 2004-03 ,pp. : 747-753

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR Study of Curcumine Derivatives as HIV-1 Integrase Inhibitors

Current Computer - Aided Drug Design, Vol. 9, Iss. 1, 2013-03 ,pp. : 141-150

Bentham Science Publishers

Access to resources Recommend Favorite

A QSAR Study of the Acrylpimaric Acid Derivatives as the Inhibitors of NCI-H460

Letters in Drug Design & Discovery, Vol. 11, Iss. 1, 2014-01 ,pp. : 59-66

Bentham Science Publishers

Access to resources Recommend Favorite